Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study.

Fantony JJ, Howard LE, Csizmadi I, Armstrong AJ, Lark AL, Galet C, Aronson WJ, Freedland SJ.

Biomark Med. 2018 Jul;12(7):727-736. doi: 10.2217/bmm-2017-0322. Epub 2018 Jun 15.

PMID:
29902938
2.

Safety and effectiveness of Factor Eight Inhibitor Bypassing Activity for direct oral anticoagulant-related hemorrhage reversal.

Engelbart JM, Zepeski A, Galet C, Policeni B, Skeete DA, Faine BA.

Am J Emerg Med. 2018 May 17. pii: S0735-6757(18)30400-5. doi: 10.1016/j.ajem.2018.05.023. [Epub ahead of print]

PMID:
29802004
3.

Phase II prospective randomized trial of weight loss prior to radical prostatectomy.

Henning SM, Galet C, Gollapudi K, Byrd JB, Liang P, Li Z, Grogan T, Elashoff D, Magyar CE, Said J, Cohen P, Aronson WJ.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):212-220. doi: 10.1038/s41391-017-0001-1. Epub 2017 Dec 4.

4.

Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.

Liu S, Cadaneanu RM, Zhang B, Huo L, Lai K, Li X, Galet C, Grogan TR, Elashoff D, Freedland SJ, Rettig M, Aronson WJ, Knudsen BS, Lewis MS, Garraway IP.

PLoS One. 2016 Oct 6;11(10):e0163232. doi: 10.1371/journal.pone.0163232. eCollection 2016.

5.

YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence.

Sheridan CM, Grogan TR, Nguyen HG, Galet C, Rettig MB, Hsieh AC, Ruggero D.

Oncotarget. 2015 Apr 10;6(10):7470-80.

6.

Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.

Gollapudi K, Galet C, Grogan T, Zhang H, Said JW, Huang J, Elashoff D, Freedland SJ, Rettig M, Aronson WJ.

Am J Cancer Res. 2013 Nov 1;3(5):523-9. eCollection 2013.

7.

Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy.

Galet C, Gollapudi K, Stepanian S, Byrd JB, Henning SM, Grogan T, Elashoff D, Heber D, Said J, Cohen P, Aronson WJ.

Cancer Prev Res (Phila). 2014 Jan;7(1):97-104. doi: 10.1158/1940-6207.CAPR-13-0261. Epub 2013 Oct 29.

8.

Effects of calorie restriction and IGF-1 receptor blockade on the progression of 22Rv1 prostate cancer xenografts.

Galet C, Gray A, Said JW, Castor B, Wan J, Beltran PJ, Calzone FJ, Elashoff D, Cohen P, Aronson WJ.

Int J Mol Sci. 2013 Jul 3;14(7):13782-95. doi: 10.3390/ijms140713782.

9.

Effect of a low-fat diet combined with IGF-1 receptor blockade on 22Rv1 prostate cancer xenografts.

Konijeti R, Koyama S, Gray A, Barnard RJ, Said JW, Castor B, Elashoff D, Wan J, Beltran PJ, Calzone FJ, Cohen P, Galet C, Aronson WJ.

Mol Cancer Ther. 2012 Jul;11(7):1539-46. doi: 10.1158/1535-7163.MCT-11-1003. Epub 2012 May 4.

10.

Follicle development in cryopreserved bitch ovarian tissue grafted to immunodeficient mouse.

Commin L, Buff S, Rosset E, Galet C, Allard A, Bruyere P, Joly T, Guérin P, Neto V.

Reprod Fertil Dev. 2012;24(3):461-71. doi: 10.1071/RD11166.

PMID:
22401278
11.

Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.

Aronson WJ, Kobayashi N, Barnard RJ, Henning S, Huang M, Jardack PM, Liu B, Gray A, Wan J, Konijeti R, Freedland SJ, Castor B, Heber D, Elashoff D, Said J, Cohen P, Galet C.

Cancer Prev Res (Phila). 2011 Dec;4(12):2062-71. doi: 10.1158/1940-6207.CAPR-11-0298. Epub 2011 Oct 25.

12.

Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model.

Gray A, Aronson WJ, Barnard RJ, Mehta H, Wan J, Said J, Cohen P, Galet C.

J Endocrinol. 2011 Dec;211(3):297-304. doi: 10.1530/JOE-11-0240. Epub 2011 Sep 8.

13.

IGFBP-3 is a metastasis suppression gene in prostate cancer.

Mehta HH, Gao Q, Galet C, Paharkova V, Wan J, Said J, Sohn JJ, Lawson G, Cohen P, Cobb LJ, Lee KW.

Cancer Res. 2011 Aug 1;71(15):5154-63. doi: 10.1158/0008-5472.CAN-10-4513. Epub 2011 Jun 22.

14.

A case report of an ectopic fetus in a cat.

Rosset E, Galet C, Buff S.

J Feline Med Surg. 2011 Aug;13(8):610-3. doi: 10.1016/j.jfms.2011.04.003.

PMID:
21641255
15.

The beta104-109 sequence is essential for the secretion of correctly folded single-chain beta alpha horse LH/CG and for its FSH activity.

Galet C, Guillou F, Foulon-Gauze F, Combarnous Y, Chopineau M.

J Endocrinol. 2009 Oct;203(1):167-74. doi: 10.1677/JOE-09-0141. Epub 2009 Jul 9.

PMID:
19589909
16.

Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells.

Galet C, Ascoli M.

Cell Signal. 2008 Oct;20(10):1822-9. doi: 10.1016/j.cellsig.2008.06.005. Epub 2008 Jun 19.

17.
19.

Association/dissociation of gonadotropin subunits involves disulfide bridge disruption which is influenced by carbohydrate moiety.

Galet C, Lecompte F, Combarnous Y.

Biochem Biophys Res Commun. 2004 Nov 12;324(2):868-73.

PMID:
15474508
20.

Identification of amino-acids in the alpha-subunit first and third loops that are crucial for the heterospecific follicle-stimulating hormone activity of equid luteinizing hormone/choriogonadotropin.

Chopineau M, Martinat N, Gibrat JF, Galet C, Lecompte F, Foulon-Gauze F, Pourchet C, Guillou F, Combarnous Y.

Eur J Endocrinol. 2004 Jun;150(6):877-84. Erratum in: Eur J Endocrinol. 2004 Jul;151(1):157.

PMID:
15191359
21.
23.

Postendocytotic trafficking of the follicle-stimulating hormone (FSH)-FSH receptor complex.

Krishnamurthy H, Kishi H, Shi M, Galet C, Bhaskaran RS, Hirakawa T, Ascoli M.

Mol Endocrinol. 2003 Nov;17(11):2162-76. Epub 2003 Aug 7.

PMID:
12907758
24.

The association of arrestin-3 with the follitropin receptor depends on receptor activation and phosphorylation.

Krishnamurthy H, Galet C, Ascoli M.

Mol Cell Endocrinol. 2003 Jun 30;204(1-2):127-40.

PMID:
12850288
25.

Intra- and inter-provenance variability in phloem phenols of Picea abies and relationship to a bark beetle-associated fungus.

Lieutier F, Brignolas F, Sauvard D, Yart A, Galet C, Brunet M, van de Sype H.

Tree Physiol. 2003 Mar;23(4):247-56.

PMID:
12566260
27.
30.

Conformational stability and in vitro bioactivity of porcine luteinizing hormone.

Burova T, Lecompte F, Galet C, Monsallier F, Delpech S, Haertlé T, Combarnous Y.

Mol Cell Endocrinol. 2001 May 15;176(1-2):129-34.

PMID:
11369452
31.

Expression of a single betaalpha chain protein of equine LH/CG in milk of transgenic rabbits and its biological activity.

Galet C, Le Bourhis CM, Chopineau M, Le Griec G, Perrin A, Magallon T, Attal J, Viglietta C, Houdebine LM, Guillou F.

Mol Cell Endocrinol. 2001 Mar 28;174(1-2):31-40.

PMID:
11306169
32.

beta-Subunit 102-104 residues are crucial to confer FSH activity to equine LH/CG but are not sufficient to confer FSH activity to human CG.

Chopineau M, Martinat N, Galet C, Guillou F, Combarnous Y.

J Endocrinol. 2001 Apr;169(1):55-63.

PMID:
11250646
33.

Expression of an in vitro biologically active equine LH/CG without C-terminal peptide (CTP) and/or beta26-110 disulphide bridge.

Galet C, Chopineau M, Martinat N, Combarnous Y, Guillou F.

J Endocrinol. 2000 Oct;167(1):117-24.

PMID:
11018759
34.

[Effects of clonidine on postoperative shivers: a double blind study].

Ang ET, Khon S, Goldfarb G, Debaene B, Galet C, Jolis P.

Ann Fr Anesth Reanim. 1989;8 Suppl:R200. French. No abstract available.

PMID:
2690686
35.

[Duration of analgesia after crural nerve block: effect of the addition of clonidine to xylocaine].

Ang ET, Khon S, Goldfarb G, Debaene B, Galet C, Jolis P.

Ann Fr Anesth Reanim. 1989;8 Suppl:R213. French. No abstract available.

PMID:
2604174
36.

[Duration of analgesia after crural nerve block: effect of the addition of clonidine to bupivacaine].

Ang ET, Khon S, Goldfarb G, Debaene B, Galet C, Jolis P.

Ann Fr Anesth Reanim. 1989;8 Suppl:R212. French. No abstract available.

PMID:
2604173
37.

[Incidence of headache after continuous spinal anesthesia: a prospective study].

Ang ET, Kry D, Khon S, Delefosse D, Galet C, Goldfarb G, Jolis P.

Ann Fr Anesth Reanim. 1989;8 Suppl:R162. French. No abstract available.

PMID:
2604121
38.

[Incidence of local complications after spinal anesthesia in patients treated with low molecular weight heparin].

Ang ET, Khon S, Delefosse D, Galet C, Goldfarb G, Jolis P.

Ann Fr Anesth Reanim. 1989;8 Suppl:R163. French. No abstract available.

PMID:
2557780
39.

[Postoperative analgesia: epidural injection of dexamethasone sodium phosphate].

Ang ET, Goldfarb G, Kohn S, Galet C, Bex M, Deburge A, Jolis P.

Ann Fr Anesth Reanim. 1988;7(4):289-93. French.

PMID:
2974259

Supplemental Content

Support Center